doctors are worried about prescribing glp 1 GLP-1 microdosing is popular, but there's little evidence it works What's It Like to Get
Description
Allen, J
:max_bytes(150000):strip_icc()/HEALTH-DWL-frame-final-ozempic-prescription-74e98f632e6b4b509f04a5f4381d8e2e.jpg)
Have more questions about GLP-1 drugs, breast cancer risk, talk to your medical care team

SURPASS-1 examined tirzepatide monotherapy in treatment-naive patients with type 2 diabetes
We update this list as new data comes in

Commercially insured patients show a similar trend: 36% who began GLP-1 therapy in 2024 did not add another drug within a year, a significant rise from 13% in 2020

BMC Gastroenterol (2016) 16:22
